A gene therapy for an inherited immune disease completes a 27-year journey.
Millions more could be exposed to the virus by 2018, the earliest a vaccine will be ready.
The first gene therapy approved in the Western world costs $1 million and has been used just once. The doctor who tried it says the price is “absolutely too high.”
Spider silk has the ability to resolve features smaller than any ordinary microscope can see, say materials scientists.
AbbVie’s purchase of the cancer fighting startup backed by Peter Thiel’s Founders Fund bodes well for biotech funding.
Customized, printed orthopedic implants could be the future. In the meantime, the new manufacturing method is helping companies cut costs.
Study of exceptionally healthy old people fails to trace their well-being to specific genes.
Uncertainty about future regulations clouds the future of agricultural biotechnology in the U.S.
Complexity theorists and biologists reveal how benefits spread super-exponentially through populations.
Inspired by science fiction. Driven by science. Enabled by innovation.